Camp4 Therapeutics (CAMP) Capital Expenditures (2023 - 2025)
Camp4 Therapeutics recorded quarterly Capital Expenditures of $279000.0 in Q2 2025, up 256.74% quarter-over-quarter from -$178000.0 in Q4 2024, and up 71.17% year-over-year from $163000.0 in Q2 2024.
Camp4 Therapeutics' Capital Expenditures history runs 3 years deep, the most recent figure standing at $279000.0 for Q2 2025.
- In Q2 2025, Capital Expenditures rose 71.17% year-over-year to $279000.0; the TTM figure through Mar 2026 stood at $279000.0 (up 1960.0% YoY), while the FY2025 annual figure was $279000.0, changed N/A from the prior year.
- Capital Expenditures came in at $279000.0 for Q2 2025 at Camp4 Therapeutics, up from -$178000.0 in the prior quarter.
- In the past five years, Capital Expenditures ranged from a high of $279000.0 in Q2 2025 to a low of -$178000.0 in Q4 2024.
- A 3-year average of $47000.0 and a median of $15000.0 in 2024 frame the typical range for Capital Expenditures.
- Across the five-year window, Capital Expenditures tumbled 304.55% in 2024 and jumped 71.17% in 2025, its largest moves.
- Camp4 Therapeutics' Capital Expenditures stood at -$44000.0 in 2023, then sank by 304.55% to -$178000.0 in 2024, then jumped by 256.74% to $279000.0 in 2025.
- According to Business Quant data, Capital Expenditures over the past three periods registered $279000.0, -$178000.0, and $163000.0 for Q2 2025, Q4 2024, and Q2 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 133.40 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 230.60 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 21.83 Mn |
| 10 | Camp4 Therapeutics | 245.89 Mn | 245.89 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 279,000.00 |
| Jun 30, 2025 | 279,000.00 |
| Dec 31, 2024 | -178,000.00 |
| Dec 31, 2024 | -178,000.00 |
| Jun 30, 2024 | 163,000.00 |
| Jun 30, 2024 | 163,000.00 |
| Mar 31, 2024 | 15,000.00 |
| Mar 31, 2024 | 15,000.00 |
| Dec 31, 2023 | -44,000.00 |
| Dec 31, 2023 | -44,000.00 |